Louisiana 2014 2014 Regular Session

Louisiana Senate Bill SB496 Comm Sub / Analysis

                    Heitmeier (SB 496)	Act No. 865
Prior law provided no prescription for a Schedule II substance may be refilled.
New law provides a Schedule II prescription may not be filled more than 90 days after the
date of the prescription.
New law provides a pharmacist not dispense more than a ten-day supply at a dosage not to
exceed the United States Food and Drug Administration's approved labeling for the
medication if the prescriber is not licensed by the state of Louisiana, and the medication is
an opiod derivative Schedule II or an opiod derivative Schedule III controlled dangerous
substance. Furthermore, the dispensing pharmacist shall notify the prescriber of the supply
dispensed and the cancellation of the remainder of the prescription.
New law provides within 60 days of the dispensing of a medication pursuant to new law,
such medication shall not be dispensed again for the individual by a prescriber not licensed
by the state.
New law provides a prescriber shall access the Prescription Monitoring Program prior to
initially prescribing any Schedule II controlled dangerous substance to a patient for the
treatment of non-cancer-related chronic or intractable pain.
Effective August 1, 2014.
(Amends R.S. 40:978(A); adds R.S. 40:978(E) and (F))